WHO ICTRP trial
NATURAL KILLER CELL RECEPTOR VARIABILITY DURING THE MENSTRUAL CYCLE
NL-OMON50034 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON50034 |
|---|---|
| Public title | NATURAL KILLER CELL RECEPTOR VARIABILITY DURING THE MENSTRUAL CYCLE |
| Scientific title | NATURAL KILLER CELL RECEPTOR VARIABILITY DURING THE MENSTRUAL CYCLE - LILAC |
| Primary sponsor | Medisch Universitair Ziekenhuis Maastricht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | Menstrual cycle;10021460;10013326;Menstrual cycle |
| Interventions | ;Menstrual cycle;Natural Killer cell |
| Registration date | Jul 1, 2020 |
| Target size | 12 |
| Secondary IDs | NL70964.068.19 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: